INFLUENCE OF HISTOLOGICAL BONE MARROW FINDINGS ON OUTCOME IN 1175 PATIENTS SUFFERING FROM MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Blum, S. [1 ]
Baghikar, S. [2 ]
Braunstein, S. [2 ]
Reinecke, P. [2 ]
Schmidt-Graeff, A. [3 ]
Schapira, M. [1 ]
Germing, U. [2 ]
机构：
[1] CHU Vaudois, CH-1011 Lausanne, Switzerland
[2] Univ Dusseldorf, Dusseldorf, Germany
[3] Univ Freiburg, Freiburg, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0709
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [31] BONE MARROW OSTEOPONTIN AS A PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROME
    Kim, S.
    Ji, Y. S.
    Yun, J.
    Kim, H. J.
    Kim, K. H.
    Kim, H. J.
    Lee, S. C.
    Bae, S. B.
    Kim, C. K.
    Lee, N. S.
    Lee, K. T.
    Park, S. K.
    Won, J. H.
    Hong, D. S.
    HAEMATOLOGICA, 2015, 100 : 723 - 723
  • [32] Allogeneic bone marrow transplantation for children with myelodysplastic syndrome
    Uçkan, D
    Çetin, M
    Hiçsönmez, G
    Tezcan, I
    Tuncer, AM
    TURKISH JOURNAL OF PEDIATRICS, 2000, 42 (03) : 192 - 197
  • [33] Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes
    Schildgen, Verena
    Luesebrink, Jessica
    Tillmann, Ramona Liza
    Wulfert, Michael
    Gattermann, Norbert
    Schildgen, Oliver
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2011, 5 (04) : 221 - 222
  • [34] Incidence of nucleoli in erythroblasts in patients suffering from refractory anemia of myelodysplastic syndrome
    Smetana, K
    Jirásková, I
    Cermák, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1999, 63 (05) : 332 - 336
  • [35] BONE MARROW STUDIES IN PATIENTS SUFFERING FROM INFECTIONS AND RECEIVING CHLORAMPHENICOL
    CHOREMIS, CB
    ASKOUNI, AD
    MEGAS, HA
    ACTA PAEDIATRICA, 1963, 52 (02) : 136 - &
  • [36] DOES BONE MARROW FIBROSIS AFFECT THE CLINICAL OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROME OR SECONDARY ACUTE MYELOID LEUKAEMIA TREATED WITH AZACITIDINE?
    Yiu, R.
    Lao, Z.
    Lim, Y. J.
    Ho, A.
    Kam, G.
    HAEMATOLOGICA, 2012, 97 : 142 - 142
  • [37] Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromes
    V Mattijssen
    A Schattenberg
    N Schaap
    F Preijers
    T De Witte
    Bone Marrow Transplantation, 1997, 19 : 791 - 794
  • [38] Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromes
    Mattijssen, V
    Schattenberg, A
    Schaap, N
    Preijers, F
    DeWitte, T
    BONE MARROW TRANSPLANTATION, 1997, 19 (08) : 791 - 794
  • [39] ABERRANT IMMUNE LANDSCAPE IN BONE MARROW OF HIGH-RISK MYELODYSPLASTIC SYNDROME PATIENTS
    Rai, R.
    Patel, F.
    Feld, J.
    Melana, S.
    Demakos, E.
    Horowitz, A.
    Silverman, L.
    LEUKEMIA RESEARCH, 2023, 128
  • [40] Thalidomide significantly modifies bone marrow microenvironment in myelodysplastic syndrome (MDS) patients.
    Alvi, S
    Borok, RZ
    Shaher, A
    Anthwal, S
    Shaikh, M
    Alvi, I
    Tahir, S
    John, P
    Shetty, V
    Galili, N
    Raza, A
    BLOOD, 2002, 100 (11) : 375A - 375A
12345